Type I interferon signature strength correlates with alloimmunization-associated transcriptomic programs in systemic lupus erythematosus: A multi-cohort analysis

Jaeeun Yoo · 2026

Read Type I interferon signature strength correlates with alloimmunization-associated transcriptomic programs in systemic lupus erythematosus: A multi-cohort analysis by Jaeeun Yoo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13577513.txt.

Description

Jaeeun Yoo studies why some lupus patients make antibodies against donated red blood cells, in a 2026 analysis. Such alloimmunization is a real risk for patients who receive transfusions, and its triggers in humans are poorly known. In mice, type I interferon signaling drives the process. Lupus keeps that same signaling switched on, and lupus patients show high rates of the complication. Yoo mined three public gene data sets covering 150 lupus patients.

In all three sets, interferon scores ran higher in lupus blood than in healthy blood. Patients with strong interferon signals showed gene programs tied to alloimmunization and to antibody-making cells. The two scores moved together in every set, while a related helper-cell program showed no link. Yoo names the interferon score a candidate warning marker for transfusion risk.

Catalog record

CREATORJaeeun Yoo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13577513

Browse the full library · About the Tower of Babel